NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Ebru Erbay
Altos Labs - San Francisco / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 182555
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ebru Erbay's MOST POPULAR ARTICLES
1-)
Nutrient sensing and inflammation in metabolic diseases GS Hotamisligil, E Erbay Nature Reviews Immunology 8 (12), 923-934, 2008 11702008
2-)
Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosisE Erbay, VR Babaev, JR Mayers, L Makowski, KN Charles, ME Snitow, ...Nature medicine 15 (12), 1383-1391, 20095592009
3-)
Handbook of Obesity--Volume 1: Epidemiology, Etiology, and PhysiopathologyGA BrayCRC Press, 20145582014
4-)
Regulation of macrophage immunometabolism in atherosclerosisGJ Koelwyn, EM Corr, E Erbay, KJ MooreNature immunology 19 (6), 526-537, 20184082018
5-)
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular diseaseG Tuncman, E Erbay, X Hom, I De Vivo, H Campos, EB Rimm, ...Proceedings of the National Academy of Sciences 103 (18), 6970-6975, 20063602006
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept